RA CAPITAL MANAGEMENT, L.P.'s Net Worth

$2.54 Billion

Who is RA CAPITAL MANAGEMENT, L.P.?

RA CAPITAL MANAGEMENT, L.P. has an estimated net worth of $2.54 Billion. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Vaxcyte, Inc., Dicerna Pharmaceuticals Inc, Eidos Therapeutics, Inc., iTeos Therapeutics, Inc., Mineralys Therapeutics, Inc., Cytek Biosciences, Inc., PMV Pharmaceuticals, Inc., Nkarta, Inc., DICE Therapeutics, Inc., SANGAMO BIOSCIENCES INC, Icosavax, Inc., Tyra Biosciences, Inc., MIRAGEN THERAPEUTICS, INC., Inhibrx, Inc., RxSight, Inc., Phathom Pharmaceuticals, Inc., Dyne Therapeutics, Inc., TG THERAPEUTICS, INC., Aclaris Therapeutics, Inc., Eiger BioPharmaceuticals, Inc., Eliem Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Verastem, Inc., Janux Therapeutics, Inc., Aerovate Therapeutics, Inc., Forma Therapeutics Holdings, Inc., Therapeutics Acquisition Corp., G1 Therapeutics, Inc., ARVINAS INC., Synthorx, Inc., CURIS INC, Acumen Pharmaceuticals, Inc., 89bio, Inc., Solid Biosciences Inc., Inozyme Pharma, Inc., Pandion Therapeutics, Inc., Iterum Therapeutics plc, Kala Pharmaceuticals, Inc., Orchard Therapeutics plc, scPharmaceuticals Inc., Satsuma Pharmaceuticals, Inc., Akouos, Inc., Cardiff Oncology, Inc., Wave Life Sciences Ltd., Werewolf Therapeutics, Inc., Enliven Therapeutics, Inc., Ra Pharmaceuticals, Inc., Fulcrum Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, ARS Pharmaceuticals, Inc., PepGen Inc., Black Diamond Therapeutics, Inc., DERMA SCIENCES, INC., SEQUENOM INC, BIOSPECIFICS TECHNOLOGIES CORP, Acrivon Therapeutics, Inc., ARADIGM CORP, and LIPID SCIENCES INC/.

SEC CIK

RA CAPITAL MANAGEMENT, L.P.'s CIK is 0001346824

Past Insider Trading and Trends

2008 was RA CAPITAL MANAGEMENT, L.P.'s most active year for acquiring shares with 337 total transactions. RA CAPITAL MANAGEMENT, L.P.'s most active month to acquire stocks was the month of May. 2014 was RA CAPITAL MANAGEMENT, L.P.'s most active year for disposing of shares, totalling 166 transactions. RA CAPITAL MANAGEMENT, L.P.'s most active month to dispose stocks was the month of August. 2020 saw RA CAPITAL MANAGEMENT, L.P. paying a total of $343,239,212.72 for 42,610,963 shares, this is the most they've acquired in one year. In 2020 RA CAPITAL MANAGEMENT, L.P. cashed out on 129,210,338 shares for a total of $1,603,221,525.90, their largest year based on trade value.